The DOI matches its Crossref record; 213 of the 213 references it cites were found in a registry or an index.
The basics of epithelial–mesenchymal transition (EMT): A study from a structure, dynamics, and functional perspective
Abstract
Epithelial–mesenchymal transition (EMT) is a key step in transdifferentiation process in solid cancer development. Forthcoming evidence suggest that the stratified program transforms polarized, immotile epithelial cells to migratory mesenchymal cells associated with enhancement of breast cancer stemness, metastasis, and drug resistance. It involves primarily several signaling pathways, such as transforming growth factor‐β (TGF‐β), cadherin, notch, plasminogen activator protein inhibitor, urokinase plasminogen activator, and WNT/beta catenin pathways. However, current understanding on the crosstalk of multisignaling pathways and assemblies of key transcription factors remain to be explored. In this review, we focus on the crosstalk of signal transduction pathways linked to the current therapeutic and drug development strategies. We have also performed the computational modeling on indepth the structure and conformational dynamic studies of regulatory proteins and analyze molecular interactions with their associate factors to understand the complicated process of EMT in breast cancer progression and metastasis. Electrostatic potential surfaces have been analyzed that help in optimization of electrostatic interactions between the protein and its ligand. Therefore, understanding the biological implications underlying the EMT process through molecular biology with biocomputation and structural biology approaches will enable the development of new therapeutic strategies to sensitize tumors to conventional therapy and suppress their metastatic phenotype.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Hallmarks of Cancer: The Next Generation
Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590
Bartel (2004) · doi:10.1016/s0092-8674(04)00045-5 · Cited by 34,714
Prospective identification of tumorigenic breast cancer cells
Al-Hajj, M., Wicha, M. S., Benito-Hernandez, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,370
The basics of epithelial-mesenchymal transition
Kalluri, R., & Weinberg, R. A. (2009) · Journal of Clinical Investigation · doi:10.1172/jci39104 · Cited by 10,196
Epithelial-Mesenchymal Transitions in Development and Disease
Thiery, J. P., Acloque, H., Huang, R. Y. J., & Nieto, M. A. (2009) · Cell · doi:10.1016/j.cell.2009.11.007 · Cited by 9,931
The Epithelial-Mesenchymal Transition Generates Cells with Properties of Stem Cells
Mani, S. A., Guo, W., Liao, M.-J., Eaton, E. N., Ayyanan, A., Zhou, A. Y., Brooks, M., Reinhard, F., Zhang, C. C., Shipitsin, M., et al. (2008) · Cell · doi:10.1016/j.cell.2008.03.027 · Cited by 8,672
Molecular mechanisms of epithelial–mesenchymal transition
Lamouille, S., Xu, J., & Derynck, R. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3758 · Cited by 8,091
Epithelial–mesenchymal transitions in tumour progression
Thiery, J. P. (2002) · Nature Reviews Cancer · doi:10.1038/nrc822 · Cited by 6,628
New functions for the matrix metalloproteinases in cancer progression
Egeblad, M., & Werb, Z. (2002) · Nature Reviews Cancer · doi:10.1038/nrc745 · Cited by 6,108
Mechanisms of TGF-β Signaling from Cell Membrane to the Nucleus
Shi, Y., & Massagué, J. (2003) · Cell · doi:10.1016/s0092-8674(03)00432-x · Cited by 5,857
Wnt/β-Catenin Signaling: Components, Mechanisms, and Diseases
MacDonald, B. T., Tamai, K., & He, X. (2009) · Developmental Cell · doi:10.1016/j.devcel.2009.06.016 · Cited by 5,583
The pathogenesis of cancer metastasis: the ‘seed and soil’ hypothesis revisited
Fidler, I. J. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1098 · Cited by 4,686 · cited 2×
“Cancer metastasis is a complex process where the variety of alternations occur termed as the invasion‐metastasis cascade (Croker & Allan, 2008; Fidler, 2003) followed by a variation of the gene expression signatures and cellular morphology (Fidler, 2003).”
BackgroundKalluri, R., & Zeisberg, M. (2006) · Nature Reviews Cancer · doi:10.1038/nrc1877 · Cited by 4,538
Dissemination and growth of cancer cells in metastatic sites
Chambers, A. F., Groom, A. C., & MacDonald, I. C. (2002) · Nature Reviews Cancer · doi:10.1038/nrc865 · Cited by 3,911
Twist, a Master Regulator of Morphogenesis, Plays an Essential Role in Tumor Metastasis
Yang, J., Mani, S. A., Donaher, J. L., Ramaswamy, S., Itzykson, R. A., Come, C., Savagner, P., Gitelman, I., Richardson, A., & Weinberg, R. A. (2004) · Cell · doi:10.1016/j.cell.2004.06.006 · Cited by 3,855
Temsirolimus, Interferon Alfa, or Both for Advanced Renal-Cell Carcinoma
Hudes, G., Carducci, M., Tomczak, P., Dutcher, J., Figlin, R., Kapoor, A., Staroslawska, E., Sosman, J., McDermott, D., Bodrogi, I., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa066838 · Cited by 3,647
Targeting multidrug resistance in cancer
Szakács, G., Paterson, J. K., Ludwig, J. A., Booth-Genthe, C., & Gottesman, M. M. (2006) · Nature Reviews Drug Discovery · doi:10.1038/nrd1984 · Cited by 3,609
Snail, Zeb and bHLH factors in tumour progression: An alliance against the epithelial phenotype?
Peinado, H., Olmeda, D., & Cano, A. (2007) · Nature reviews. Cancer · doi:10.1038/nrc2131 · Cited by 3,121
Fibroblast growth factor signalling: from development to cancer
Turner, N., & Grose, R. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2780 · Cited by 2,693
Batlle, E., Sancho, E., Francí, C., Domínguez, D., Monfar, M., Baulida, J., & García de Herreros, A. (2000) · Nature Cell Biology · doi:10.1038/35000034 · Cited by 2,666
Epithelial-mesenchymal transition and its implications for fibrosis
Kalluri, R., & Neilson, E. G. (2003) · Journal of Clinical Investigation · doi:10.1172/jci200320530 · Cited by 2,649
Met, metastasis, motility and more
Birchmeier, C., Birchmeier, W., Gherardi, E., & Vande Woude, G. F. (2003) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1261 · Cited by 2,602
Targeting cancer with small molecule kinase inhibitors
Zhang, J., Yang, P. L., & Gray, N. S. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2559 · Cited by 2,576
Ignotz, R. A., & Massagué, J. (1986) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)35666-1 · Cited by 2,492
Biomarkers for epithelial-mesenchymal transitions
Zeisberg, M., & Neilson, E. G. (2009) · Journal of Clinical Investigation · doi:10.1172/jci36183 · Cited by 2,299 · cited 1×
“…increased motility and has the potential to cross through the basal membrane by loosing the adherent and tight junction that helps them to communicate with the neighboring cells (Figure 2; Heerboth et al., 2015; Kalluri & Neilson, 2003; Kim et al., 2017; Son & Moon, 2010; Zeisberg & Neilson, 2009).”
BackgroundSotiriou, C., Neo, S.-Y., McShane, L. M., Korn, E. L., Long, P. M., Jazaeri, A., Martiat, P., Fox, S. B., Harris, A. L., & Liu, E. T. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1732912100 · Cited by 1,993
SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS
Feng, X.-H., & Derynck, R. (2005) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.21.022404.142018 · Cited by 1,869
Molecular requirements for epithelial–mesenchymal transition during tumor progression
Huber, M. A., Kraut, N., & Beug, H. (2005) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2005.08.001 · Cited by 1,821
Identification of Smad7, a TGFβ-inducible antagonist of TGF-β signalling
Nakao, A., Afrakhte, M., Morn, A., Nakayama, T., Christian, J. L., Heuchel, R., Itoh, S., Kawabata, M., Heldin, N.-E., Heldin, C.-H., et al. (1997) · Nature · doi:10.1038/39369 · Cited by 1,809
Intrinsic Resistance of Tumorigenic Breast Cancer Cells to Chemotherapy
Li, X., Lewis, M. T., Huang, J., Gutierrez, C., Osborne, C. K., Wu, M.-F., Hilsenbeck, S. G., Pavlick, A., Zhang, X., Chamness, G. C., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn123 · Cited by 1,794
Signaling mechanisms of the epithelial-mesenchymal transition
Gonzalez, D. M., & Medici, D. (2014) · Science Signaling · doi:10.1126/scisignal.2005189 · Cited by 1,721
The snail superfamily of zinc-finger transcription factors
Nieto, M. A. (2002) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm757 · Cited by 1,719
Molecular and Biological Properties of the Vascular Endothelial Growth Factor Family of Proteins
FERRARA, N., HOUCK, K., JAKEMAN, L., & LEUNG, D. W. (1992) · Endocrine Reviews · doi:10.1210/edrv-13-1-18 · Cited by 1,655
Generation of Breast Cancer Stem Cells through Epithelial-Mesenchymal Transition
Morel, A.-P., Lièvre, M., Thomas, C., Hinkal, G., Ansieau, S., & Puisieux, A. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002888 · Cited by 1,645
Zhou, B. P., Deng, J., Xia, W., Xu, J., Li, Y. M., Gunduz, M., & Hung, M.-C. (2004) · Nature Cell Biology · doi:10.1038/ncb1173 · Cited by 1,581
Epithelial Mesenchymal Transition in Tumor Metastasis
Mittal, V. (2018) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev-pathol-020117-043854 · Cited by 1,528
Epithelial-Mesenchymal Transitions
Kang, Y., & Massagué, J. (2004) · Cell · doi:10.1016/j.cell.2004.07.011 · Cited by 1,525
The Two-Handed E Box Binding Zinc Finger Protein SIP1 Downregulates E-Cadherin and Induces Invasion
Comijn, J., Berx, G., Vermassen, P., Verschueren, K., van Grunsven, L., Bruyneel, E., Mareel, M., Huylebroeck, D., & van Roy, F. (2001) · Molecular Cell · doi:10.1016/s1097-2765(01)00260-x · Cited by 1,394
Direct regulation of TWIST by HIF-1α promotes metastasis
Yang, M.-H., Wu, M.-Z., Chiou, S.-H., Chen, P.-M., Chang, S.-Y., Liu, C.-J., Teng, S.-C., & Wu, K.-J. (2008) · Nature Cell Biology · doi:10.1038/ncb1691 · Cited by 1,345
Hayashi, H., Abdollah, S., Qiu, Y., Cai, J., Xu, Y.-Y., Grinnell, B. W., Richardson, M. A., Topper, J. N., Gimbrone, M. A., Wrana, J. L., et al. (1997) · Cell · doi:10.1016/s0092-8674(00)80303-7 · Cited by 1,334
MMP-9 Supplied by Bone Marrow–Derived Cells Contributes to Skin Carcinogenesis
Coussens, L. M., Tinkle, C. L., Hanahan, D., & Werb, Z. (2000) · Cell · doi:10.1016/s0092-8674(00)00139-2 · Cited by 1,306
The metastatic niche: adapting the foreign soil
Psaila, B., & Lyden, D. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2621 · Cited by 1,300
Rac1b and reactive oxygen species mediate MMP-3-induced EMT and genomic instability
Radisky, D. C., Levy, D. D., Littlepage, L. E., Liu, H., Nelson, C. M., Fata, J. E., Leake, D., Godden, E. L., Albertson, D. G., Angela Nieto, M., et al. (2005) · Nature · doi:10.1038/nature03688 · Cited by 1,284
Dissecting the metastatic cascade
Pantel, K., & Brakenhoff, R. H. (2004) · Nature Reviews Cancer · doi:10.1038/nrc1370 · Cited by 1,281
Signal Transduction by the TGF-β Superfamily
Attisano, L., & Wrana, J. L. (2002) · Science · doi:10.1126/science.1071809 · Cited by 1,268
Biological determinants of endocrine resistance in breast cancer
Musgrove, E. A., & Sutherland, R. L. (2009) · Nature Reviews Cancer · doi:10.1038/nrc2713 · Cited by 1,252
Larue, L., & Bellacosa, A. (2005) · Oncogene · doi:10.1038/sj.onc.1209091 · Cited by 1,228
Smad7 Binds to Smurf2 to Form an E3 Ubiquitin Ligase that Targets the TGFβ Receptor for Degradation
Kavsak, P., Rasmussen, R. K., Causing, C. G., Bonni, S., Zhu, H., Thomsen, G. H., & Wrana, J. L. (2000) · Molecular Cell · doi:10.1016/s1097-2765(00)00134-9 · Cited by 1,205
AACR Centennial Series: The Biology of Cancer Metastasis: Historical Perspective
Talmadge, J. E., & Fidler, I. J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-10-1040 · Cited by 1,169
Regulation of matrix biology by matrix metalloproteinases
Mott, J. D., & Werb, Z. (2004) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2004.07.010 · Cited by 1,104 · cited 1×
“Recently it has been shown that STRAP governs the inhibitory functions of SMAD7 (Liu, Li, Peng, Liu, & Liu, 2007) (Liu et al., 2006; Anastasiadis & Reynolds, 2001; Mott & Werb, 2004; Figure 5).”
BackgroundEpithelial-Mesenchymal Transition in Breast Cancer Relates to the Basal-like Phenotype
Sarrió, D., Rodriguez-Pinilla, S. M., Hardisson, D., Cano, A., Moreno-Bueno, G., & Palacios, J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2017 · Cited by 1,056
Micalizzi, D. S., Farabaugh, S. M., & Ford, H. L. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9178-9 · Cited by 984
Cancer stem cells: mirage or reality?
Gupta, P. B., Chaffer, C. L., & Weinberg, R. A. (2009) · Nature Medicine · doi:10.1038/nm0909-1010 · Cited by 979
SARA, a FYVE Domain Protein that Recruits Smad2 to the TGFβ Receptor
Tsukazaki, T., Chiang, T. A., Davison, A. F., Attisano, L., & Wrana, J. L. (1998) · Cell · doi:10.1016/s0092-8674(00)81701-8 · Cited by 968
Epithelial Plasticity: A Common Theme in Embryonic and Cancer Cells
Nieto, M. A. (2013) · Science · doi:10.1126/science.1234850 · Cited by 967
Moustakas, A., & Heldin, C.-H. (2005) · Journal of Cell Science · doi:10.1242/jcs.02554 · Cited by 958
The Stromal Proteinase MMP3/Stromelysin-1 Promotes Mammary Carcinogenesis
Sternlicht, M. D., Lochter, A., Sympson, C. J., Huey, B., Rougier, J.-P., Gray, J. W., Pinkel, D., Bissell, M. J., & Werb, Z. (1999) · Cell · doi:10.1016/s0092-8674(00)81009-0 · Cited by 924
The Role of Snail in EMT and Tumorigenesis
Wang, Y., Shi, J., Chai, K., Ying, X., & Zhou, B. (2013) · Current Cancer Drug Targets · doi:10.2174/15680096113136660102 · Cited by 875
Snail blocks the cell cycle and confers resistance to cell death
Vega, S., Morales, A. V., Ocaña, O. H., Valdés, F., Fabregat, I., & Nieto, M. A. (2004) · Genes & Development · doi:10.1101/gad.294104 · Cited by 867
Ebisawa, T., Fukuchi, M., Murakami, G., Chiba, T., Tanaka, K., Imamura, T., & Miyazono, K. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.c100008200 · Cited by 844
TNF-α/NF-κB/Snail pathway in cancer cell migration and invasion
Wu, Y., & Zhou, B. P. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6605530 · Cited by 798
The ZEB/miR‐200 feedback loop—a motor of cellular plasticity in development and cancer?
Brabletz, S., & Brabletz, T. (2010) · EMBO reports · doi:10.1038/embor.2010.117 · Cited by 793
Understanding Ras: ‘it ain’t over ’til it’s over’
Shields, J. M., Pruitt, K., McFall, A., Shaub, A., & Der, C. J. (2000) · Trends in Cell Biology · doi:10.1016/s0962-8924(00)01740-2 · Cited by 780
E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers.
Berx, G., Cleton-Jansen, A. M., Nollet, F., de Leeuw, W. J., van de Vijver, M., Cornelisse, C., & van Roy, F. (1995) · The EMBO Journal · doi:10.1002/j.1460-2075.1995.tb00301.x · Cited by 775
Tumor Morphology and Phenotypic Evolution Driven by Selective Pressure from the Microenvironment
Anderson, A. R. A., Weaver, A. M., Cummings, P. T., & Quaranta, V. (2006) · Cell · doi:10.1016/j.cell.2006.09.042 · Cited by 754
Heerboth, S., Housman, G., Leary, M., Longacre, M., Byler, S., Lapinska, K., Willbanks, A., & Sarkar, S. (2015) · Clinical and Translational Medicine · doi:10.1186/s40169-015-0048-3 · Cited by 739
Rusnak, D. W., Lackey, K. E., Affleck, K., Wood, E. R., Alligood, K. J., Rhodes, N., Keith, B. R., Murray, D. M., Knight, W. B., Mullin, R. J., et al. (2001) · PubMed · Cited by 728
Massagué, J., & Gomis, R. R. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.04.033 · Cited by 721
Li, Y., VandenBoom, T. G., Kong, D., Wang, Z., Ali, S., Philip, P. A., & Sarkar, F. H. (2009) · Cancer Research · doi:10.1158/0008-5472.can-09-1298 · Cited by 663
Development of the Proteasome Inhibitor Velcade™ (Bortezomib)
Adams, J., & Kauffman, M. (2004) · Cancer Investigation · doi:10.1081/cnv-120030218 · Cited by 654
Armstrong, A. J., Marengo, M. S., Oltean, S., Kemeny, G., Bitting, R. L., Turnbull, J. D., Herold, C. I., Marcom, P. K., George, D. J., & Garcia-Blanco, M. A. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0490 · Cited by 646
Mechanism of TGF-β signaling to growth arrest, apoptosis, and epithelial–mesenchymal transition
Heldin, C.-H., Landström, M., & Moustakas, A. (2009) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2009.01.021 · Cited by 634
A Wnt–Axin2–GSK3β cascade regulates Snail1 activity in breast cancer cells
Yook, J. I., Li, X.-Y., Ota, I., Hu, C., Kim, H. S., Kim, N. H., Cha, S. Y., Ryu, J. K., Choi, Y. J., Kim, J., et al. (2006) · Nature Cell Biology · doi:10.1038/ncb1508 · Cited by 616
Mani, S. A., Yang, J., Brooks, M., Schwaninger, G., Zhou, A., Miura, N., Kutok, J. L., Hartwell, K., Richardson, A. L., & Weinberg, R. A. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703900104 · Cited by 575
NF-κB as a therapeutic target in cancer
Orlowski, R. Z., & Baldwin, A. S. (2002) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(02)02375-4 · Cited by 553
The CD44+/CD24-phenotype is enriched in basal-like breast tumors
Honeth, G., Bendahl, P.-O., Ringnér, M., Saal, L. H., Gruvberger-Saal, S. K., Lövgren, K., Grabau, D., Fernö, M., Borg, Å., & Hegardt, C. (2008) · Breast Cancer Research · doi:10.1186/bcr2108 · Cited by 551
Cheng, G. Z., Chan, J., Wang, Q., Zhang, W., Sun, C. D., & Wang, L.-H. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-1479 · Cited by 546
Rituximab: A Review of its Use in Non-Hodgkin??s Lymphoma and Chronic Lymphocytic Leukaemia
Plosker, G. L., & Figgitt, D. P. (2003) · Drugs · doi:10.2165/00003495-200363080-00005 · Cited by 471
The Tension Mounts: Mechanics Meets Morphogenesis and Malignancy
Paszek, M. J., & Weaver, V. M. (2004) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-004-1404-x · Cited by 467
Leong, K. G., Niessen, K., Kulic, I., Raouf, A., Eaves, C., Pollet, I., & Karsan, A. (2007) · The Journal of Experimental Medicine · doi:10.1084/jem.20071082 · Cited by 467
Therapeutic modulation of Notch signalling — are we there yet?
Andersson, E. R., & Lendahl, U. (2014) · Nature Reviews Drug Discovery · doi:10.1038/nrd4252 · Cited by 457
Plasminogen activation and cancer
Behrendt, N., Høyer-Hansen, G., Johnsen, M., Lund, L. R., Ploug, M., Rømer, J., & Danø, K. (2005) · Thrombosis and Haemostasis · doi:10.1160/th05-01-0054 · Cited by 452
Evdokimova, V., Tognon, C., Ng, T., Ruzanov, P., Melnyk, N., Fink, D., Sorokin, A., Ovchinnikov, L. P., Davicioni, E., Triche, T. J., et al. (2009) · Cancer Cell · doi:10.1016/j.ccr.2009.03.017 · Cited by 444
Adam, L., Zhong, M., Choi, W., Qi, W., Nicoloso, M., Arora, A., Calin, G., Wang, H., Siefker-Radtke, A., McConkey, D., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-2245 · Cited by 412
An ESRP‐regulated splicing programme is abrogated during the epithelial–mesenchymal transition
Warzecha, C. C., Jiang, P., Amirikian, K., Dittmar, K. A., Lu, H., Shen, S., Guo, W., Xing, Y., & Carstens, R. P. (2010) · The EMBO Journal · doi:10.1038/emboj.2010.195 · Cited by 383
Stem cells and breast cancer: A field in transit
Smalley, M., & Ashworth, A. (2003) · Nature Reviews Cancer · doi:10.1038/nrc1212 · Cited by 380
Immune-Induced Epithelial to Mesenchymal Transition In vivo Generates Breast Cancer Stem Cells
Santisteban, M., Reiman, J. M., Asiedu, M. K., Behrens, M. D., Nassar, A., Kalli, K. R., Haluska, P., Ingle, J. N., Hartmann, L. C., Manjili, M. H., et al. (2009) · Cancer Research · doi:10.1158/0008-5472.can-08-3343 · Cited by 379
Direct Evidence for Epithelial-Mesenchymal Transitions in Breast Cancer
Trimboli, A. J., Fukino, K., de Bruin, A., Wei, G., Shen, L., Tanner, S. M., Creasap, N., Rosol, T. J., Robinson, M. L., Eng, C., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-2148 · Cited by 368
Mammary Stem Cells and Breast Cancer—Role of Notch Signalling
Farnie, G., & Clarke, R. B. (2007) · Stem Cell Reviews · doi:10.1007/s12015-007-0023-5 · Cited by 356
The Epithelial-to-Mesenchymal Transition and Cancer Stem Cells: A Coalition Against Cancer Therapies
Hollier, B. G., Evans, K., & Mani, S. A. (2009) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-009-9110-3 · Cited by 353
Epithelial–mesenchymal transition and the invasive potential of tumors
Gavert, N., & Ben-Ze’ev, A. (2008) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2008.03.004 · Cited by 352
Elefanty, A. G., Hariharan, I. K., & Cory, S. (1990) · The EMBO Journal · doi:10.1002/j.1460-2075.1990.tb08212.x · Cited by 344
Li, J., & Zhou, B. P. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-49 · Cited by 339
Nawshad, A., LaGamba, D., Polad, A., & Hay, E. D. (2005) · Cells Tissues Organs · doi:10.1159/000084505 · Cited by 327
Epithelial-mesenchymal Transition and Cell Invasion
Son, H.-J., & Moon, A. (2010) · Toxicological Research · doi:10.5487/tr.2010.26.4.245 · Cited by 320
Moreno-Bueno, G., Cubillo, E., Sarrió, D., Peinado, H., Rodríguez-Pinilla, S. M., Villa, S., Bolós, V., Jordá, M., Fabra, A., Portillo, F., et al. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-0479 · Cited by 320
Vascular permeability factor: A unique regulator of blood vessel function
Connolly, D. T. (1991) · Journal of Cellular Biochemistry · doi:10.1002/jcb.240470306 · Cited by 317
Epithelial mesenchymal transition traits in human breast cancer cell lines
Blick, T., Widodo, E., Hugo, H., Waltham, M., Lenburg, M. E., Neve, R. M., & Thompson, E. W. (2008) · Clinical & Experimental Metastasis · doi:10.1007/s10585-008-9170-6 · Cited by 314
Vogt, M., Munding, J., Grüner, M., Liffers, S.-T., Verdoodt, B., Hauk, J., Steinstraesser, L., Tannapfel, A., & Hermeking, H. (2011) · Virchows Archiv · doi:10.1007/s00428-010-1030-5 · Cited by 309
N-CAM modulates tumour-cell adhesion to matrix by inducing FGF-receptor signalling
Cavallaro, U., Niedermeyer, J., Fuxa, M., & Christofori, G. (2001) · Nature Cell Biology · doi:10.1038/35083041 · Cited by 307
Immunotoxins for targeted cancer therapy
Kreitman, R. J. (2006) · The AAPS Journal · doi:10.1208/aapsj080363 · Cited by 307
Kim, D., Xing, T., Yang, Z., Dudek, R., Lu, Q., & Chen, Y.-H. (2017) · Journal of Clinical Medicine · doi:10.3390/jcm7010001 · Cited by 306
Gotzmann, J., Mikula, M., Eger, A., Schulte-Hermann, R., Foisner, R., Beug, H., & Mikulits, W. (2004) · Mutation Research/Reviews in Mutation Research · doi:10.1016/s1383-5742(03)00033-4 · Cited by 305
Transactivation of Vimentin by Beta-Catenin in Human Breast Cancer Cells
Gilles, C., Polette, M., Mestdagt, M., Nawrocki-Raby, B., Ruggeri, P., Birembaut, P., & Foidart, J.-M. (2003) · International Journal of Gynecological Cancer · doi:10.1136/ijgc-00009577-200303001-00219 · Cited by 301
Hunter, K. W., Crawford, N. P., & Alsarraj, J. (2008) · Breast Cancer Research · doi:10.1186/bcr1988 · Cited by 298
Mechanisms of endocrine resistance and novel therapeutic strategies in breast cancer
Normanno, N., Di Maio, M., De Maio, E., De Luca, A., de Matteis, A., Giordano, A., Perrone, F., & _, _. (2005) · Endocrine-Related Cancer · doi:10.1677/erc.1.00857 · Cited by 286
Epithelial–mesenchymal transition and breast cancer: Role, molecular mechanisms and clinical impact
Foroni, C., Broggini, M., Generali, D., & Damia, G. (2012) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2011.11.001 · Cited by 282
Regulation of Rho GTPases by p120-catenin
Anastasiadis, P. Z., & Reynolds, A. B. (2001) · Current Opinion in Cell Biology · doi:10.1016/s0955-0674(00)00258-1 · Cited by 278
Cancer stem cells: implications for the progression and treatment of metastatic disease
Croker, A. K., & Allan, A. L. (2008) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2007.00211.x · Cited by 273
Brandes, A. A., Carpentier, A. F., Kesari, S., Sepulveda-Sanchez, J. M., Wheeler, H. R., Chinot, O., Cher, L., Steinbach, J. P., Capper, D., Specenier, P., et al. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now009 · Cited by 273
Wu, Y., Ginther, C., Kim, J., Mosher, N., Chung, S., Slamon, D., & Vadgama, J. V. (2012) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-12-0155-t · Cited by 268
Transforming Growth Factor-β as a Therapeutic Target in Hepatocellular Carcinoma
Giannelli, G., Villa, E., & Lahn, M. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-0243 · Cited by 263
ZEB/miR‐200 feedback loop: At the crossroads of signal transduction in cancer
Hill, L., Browne, G., & Tulchinsky, E. (2013) · International Journal of Cancer · doi:10.1002/ijc.27708 · Cited by 261
Hiscox, S., Jiang, W. G., Obermeier, K., Taylor, K., Morgan, L., Burmi, R., Barrow, D., & Nicholson, R. I. (2006) · International Journal of Cancer · doi:10.1002/ijc.21355 · Cited by 260
Regulation of epithelial–mesenchymal and mesenchymal–epithelial transitions by microRNAs
Lamouille, S., Subramanyam, D., Blelloch, R., & Derynck, R. (2013) · Current Opinion in Cell Biology · doi:10.1016/j.ceb.2013.01.008 · Cited by 259
The matrix metalloproteinase stromelysin-1 acts as a natural mammary tumor promoter
Sternlicht, M. D., Bissell, M. J., & Werb, Z. (2000) · Oncogene · doi:10.1038/sj.onc.1203347 · Cited by 256
uPAR induces epithelial–mesenchymal transition in hypoxic breast cancer cells
Lester, R. D., Jo, M., Montel, V., Takimoto, S., & Gonias, S. L. (2007) · The Journal of Cell Biology · doi:10.1083/jcb.200701092 · Cited by 253
Gee, J. M. W., Robertson, J. F. R., Ellis, I. O., & Nicholson, R. I. (2001) · International Journal of Cancer · doi:10.1002/1097-0215(20010720)95:4<247::aid-ijc1042>3.0.co;2-s · Cited by 249
Snail promotes Wnt target gene expression and interacts with β-catenin
Stemmer, V, de Craene, B., Berx, G., & Behrens, J. (2008) · Oncogene · doi:10.1038/onc.2008.140 · Cited by 246
Aranda, V., Haire, T., Nolan, M. E., Calarco, J. P., Rosenberg, A. Z., Fawcett, J. P., Pawson, T., & Muthuswamy, S. K. (2006) · Nature Cell Biology · doi:10.1038/ncb1485 · Cited by 243
Molecular mechanisms of metastasis in breast cancer—clinical applications
Mego, M., Mani, S. A., & Cristofanilli, M. (2010) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2010.171 · Cited by 235
Targeting Notch signaling pathway to overcome drug resistance for cancer therapy
Wang, Z., Li, Y., Ahmad, A., Azmi, A. S., Banerjee, S., Kong, D., & Sarkar, F. H. (2010) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2010.06.001 · Cited by 233
Taylor, M. A., Parvani, J. G., & Schiemann, W. P. (2010) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1007/s10911-010-9181-1 · Cited by 231
Plasminogen Activator Inhibitor 1: Physiological and Pathophysiological Roles
Binder, B. R., Christ, G., Gruber, F., Grubic, N., Hufnagl, P., Krebs, M., Mihaly, J., & Prager, G. W. (2002) · Physiology · doi:10.1152/nips.01369.2001 · Cited by 225
The Spemann organizer gene, Goosecoid , promotes tumor metastasis
Hartwell, K. A., Muir, B., Reinhardt, F., Carpenter, A. E., Sgroi, D. C., & Weinberg, R. A. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0608636103 · Cited by 220
Role of the epithelial-mesenchymal transition regulator Slug in primary human cancers
Alves, C. C. (2009) · Frontiers in Bioscience · doi:10.2741/3433 · Cited by 218
Arkadia amplifies TGF- superfamily signalling through degradation of Smad7
Koinuma, D. (2003) · The EMBO Journal · doi:10.1093/emboj/cdg632 · Cited by 215
The adaptor molecule Disabled‐2 links the transforming growth factor β receptors to the Smad pathway
Hocevar, B. A., Smine, A., Xu, X., & Howe, P. H. (2001) · The EMBO Journal · doi:10.1093/emboj/20.11.2789 · Cited by 213
Epithelial-Mesenchymal Transition and Breast Cancer
Wu, Y., Sarkissyan, M., & Vadgama, J. (2016) · Journal of Clinical Medicine · doi:10.3390/jcm5020013 · Cited by 212
Transactivation of vimentin by beta-catenin in human breast cancer cells.
Gilles, C., Polette, M., Mestdagt, M., et al. (2003) · PubMed · Cited by 210
Epithelial-Mesenchymal Transition and the Stem Cell Phenotype
Radisky, D. C., & LaBarge, M. A. (2008) · Cell Stem Cell · doi:10.1016/j.stem.2008.05.007 · Cited by 200
Alterations in Vascular Gene Expression in Invasive Breast Carcinoma
Parker, B. S., Argani, P., Cook, B. P., Liangfeng, H., Chartrand, S. D., Zhang, M., Saha, S., Bardelli, A., Jiang, Y., St. Martin, T. B., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-04-1976 · Cited by 200
Duffy, M. J., & Duggan, C. (2004) · Clinical Biochemistry · doi:10.1016/j.clinbiochem.2004.05.013 · Cited by 198
Tumor Dissemination: An EMT Affair
Thiery, J. P., & Lim, C. T. (2013) · Cancer Cell · doi:10.1016/j.ccr.2013.03.004 · Cited by 194
NCAM‐induced focal adhesion assembly: a functional switch upon loss of E‐cadherin
Lehembre, F., Yilmaz, M., Wicki, A., Schomber, T., Strittmatter, K., Ziegler, D., Kren, A., Went, P., Derksen, P. W., Berns, A., et al. (2008) · The EMBO Journal · doi:10.1038/emboj.2008.178 · Cited by 194
Axin is a scaffold protein in TGF‐β signaling that promotes degradation of Smad7 by Arkadia
Liu, W., Rui, H., Wang, J., Lin, S., He, Y., Chen, M., Li, Q., Ye, Z., Zhang, S., Chan, S. C., et al. (2006) · The EMBO Journal · doi:10.1038/sj.emboj.7601057 · Cited by 193
Tumor cell invasiveness correlates with changes in integrin expression and localization
Maschler, S., Wirl, G., Spring, H., Bredow, D. V., Sordat, I., Beug, H., & Reichmann, E. (2005) · Oncogene · doi:10.1038/sj.onc.1208423 · Cited by 190
Wang, W., McKinnie, S. M. K., Farhan, M., Paul, M., McDonald, T., McLean, B., Llorens-Cortes, C., Hazra, S., Murray, A. G., Vederas, J. C., et al. (2016) · Hypertension · doi:10.1161/hypertensionaha.115.06892 · Cited by 190
Self-citationHgs (Hrs), a FYVE Domain Protein, Is Involved in Smad Signaling through Cooperation with SARA
Miura, S., Takeshita, T., Asao, H., Kimura, Y., Murata, K., Sasaki, Y., Hanai, J.-I., Beppu, H., Tsukazaki, T., Wrana, J. L., et al. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.24.9346-9355.2000 · Cited by 182
Genetta, T., Ruezinsky, D., & Kadesch, T. (1994) · Molecular and Cellular Biology · doi:10.1128/mcb.14.9.6153 · Cited by 181
Magnani, L., Stoeck, A., Zhang, X., Lánczky, A., Mirabella, A. C., Wang, T.-L., Gyorffy, B., & Lupien, M. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1219992110 · Cited by 181
Evolutionary functional analysis and molecular regulation of the ZEB transcription factors
Gheldof, A., Hulpiau, P., van Roy, F., De Craene, B., & Berx, G. (2012) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-012-0935-3 · Cited by 177
Clinical significance of epithelial‐mesenchymal transition
Steinestel, K., Eder, S., Schrader, A. J., & Steinestel, J. (2014) · Clinical and Translational Medicine · doi:10.1186/2001-1326-3-17 · Cited by 177
STRAP and Smad7 Synergize in the Inhibition of Transforming Growth Factor β Signaling
Datta, P. K., & Moses, H. L. (2000) · Molecular and Cellular Biology · doi:10.1128/mcb.20.9.3157-3167.2000 · Cited by 175
Baritaki, S., Chapman, A., Yeung, K., Spandidos, D. A., Palladino, M., & Bonavida, B. (2009) · Oncogene · doi:10.1038/onc.2009.214 · Cited by 169
Illman, S. A., Lehti, K., Keski-Oja, J., & Lohi, J. (2006) · Journal of Cell Science · doi:10.1242/jcs.03157 · Cited by 168
Suman, S., Das, T. P., & Damodaran, C. (2013) · British Journal of Cancer · doi:10.1038/bjc.2013.642 · Cited by 166
The Transcription Factor ZEB1 Is Aberrantly Expressed in Aggressive Uterine Cancers
Spoelstra, N. S., Manning, N. G., Higashi, Y., Darling, D., Singh, M., Shroyer, K. R., Broaddus, R. R., Horwitz, K. B., & Richer, J. K. (2006) · Cancer Research · doi:10.1158/0008-5472.can-05-2881 · Cited by 165
Weng, Q., Chen, Y., Wang, H., Xu, X., Yang, B., He, Q., Shou, W., Chen, Y., Higashi, Y., van den Berghe, V., et al. (2012) · Neuron · doi:10.1016/j.neuron.2011.12.021 · Cited by 163
Protein Kinase D1 Suppresses Epithelial-to-Mesenchymal Transition through Phosphorylation of Snail
Du, C., Zhang, C., Hassan, S., Biswas, M. H. U., & Balaji, K. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4481 · Cited by 161
Souchelnytskyi, S., Nakayama, T., Nakao, A., Morén, A., Heldin, C.-H., Christian, J. L., & ten Dijke, P. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.39.25364 · Cited by 159
Epithelial-mesenchymal transition and drug resistance in breast cancer (Review)
Huang, J., Li, H., & Ren, G. (2015) · International Journal of Oncology · doi:10.3892/ijo.2015.3084 · Cited by 156
Long, J., Zuo, D., & Park, M. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m504477200 · Cited by 151
The role of the organ microenvironment in the biology and therapy of cancer metastasis
Fidler, I. J., Kim, S., & Langley, R. R. (2006) · Journal of Cellular Biochemistry · doi:10.1002/jcb.21148 · Cited by 147
Li, D.-M., & Feng, Y.-M. (2011) · Breast Cancer Research and Treatment · doi:10.1007/s10549-011-1499-x · Cited by 145
Postigo, A. A., & Dean, D. C. (2000) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.97.12.6391 · Cited by 142
Grego-Bessa, J., Díez, J., & de la Pompa, J. L. (2004) · Cell Cycle · doi:10.4161/cc.3.6.949 · Cited by 138
Priming the ‘Soil’ for Breast Cancer Metastasis: The Pre-Metastatic Niche
Psaila, B., Kaplan, R. N., Port, E. R., & Lyden, D. C. (2007) · Breast Disease · doi:10.3233/bd-2007-26106 · Cited by 135
Xie, L., Law, B. K., Aakre, M. E., Edgerton, M. E., Shyr, Y., Bhowmick, N. A., & Moses, H. L. (2003) · Breast Cancer Research · doi:10.1186/bcr640 · Cited by 134
Srivastava, R. K., Tang, S., Zhu, W., Meeker, D., & Shankar, S. (2010) · Frontiers in Bioscience-Elite · doi:10.2741/e266 · Cited by 127
Role of the Wnt Pathway in Thyroid Cancer
Sastre-Perona, A., & Santisteban, P. (2012) · Frontiers in Endocrinology · doi:10.3389/fendo.2012.00031 · Cited by 127
The Wnt Signal Transduction Pathway in Stem Cells and Cancer Cells: Influence on Cellular Invasion
Neth, P., Ries, C., Karow, M., Egea, V., Ilmer, M., & Jochum, M. (2007) · Stem Cell Reviews and Reports · doi:10.1007/s12015-007-0001-y · Cited by 127
Prospects for new lung cancer treatments that target EMT signaling
Otsuki, Y., Saya, H., & Arima, Y. (2017) · Developmental Dynamics · doi:10.1002/dvdy.24596 · Cited by 117
Foss, F. M., Demierre, M. F., & DiVenuti, G. (2005) · Blood · doi:10.1182/blood-2004-11-4570 · Cited by 115
Papadaki, M. A., Kallergi, G., Zafeiriou, Z., Manouras, L., Theodoropoulos, P. A., Mavroudis, D., Georgoulias, V., & Agelaki, S. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-651 · Cited by 113
Kim, E., Sohn, Y., & Moon, A. (2007) · Cancer Letters · doi:10.1016/j.canlet.2006.12.016 · Cited by 112
Rodon, J. A., Carducci, M. A., Sepúlveda-Sánchez, J. M., Azaro, A., Calvo, E., Seoane, J., Braña, I., Sicart, E., Gueorguieva, I., Cleverly, A., et al. (2014) · Investigational New Drugs · doi:10.1007/s10637-014-0192-4 · Cited by 110
Tang, Y., Tang, Y., & Cheng, Y.-S. (2017) · Scientific Reports · doi:10.1038/srep38232 · Cited by 109
Santibanez, J. F. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.09.003 · Cited by 108
Immune Promotion of Epithelial-mesenchymal Transition and Generation of Breast Cancer Stem Cells
Reiman, J. M., Knutson, K. L., & Radisky, D. C. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-4041 · Cited by 106
Epithelial‐to‐mesenchymal transition and cancer stem cells contribute to breast cancer heterogeneity
Hong, D., Fritz, A. J., Zaidi, S. K., van Wijnen, A. J., Nickerson, J. A., Imbalzano, A. N., Lian, J. B., Stein, J. L., & Stein, G. S. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.26847 · Cited by 104
Mitra, S. K., Lim, S.-T., Chi, A., & Schlaepfer, D. D. (2006) · Oncogene · doi:10.1038/sj.onc.1209482 · Cited by 103
The EMT spectrum and therapeutic opportunities
Voon, D. C., Huang, R. Y., Jackson, R. A., & Thiery, J. P. (2017) · Molecular Oncology · doi:10.1002/1878-0261.12082 · Cited by 103
Mehner, C., Miller, E. E., Nassar, A., Bamlet, W. R., Radisky, E. S., & Radisky, D. C. (2015) · Genes & Cancer · doi:10.18632/genesandcancer.90 · Cited by 102
Duivenvoorden, W., Hirte, H. W., & Singh, G. K. J. (1999) · Clinical & Experimental Metastasis · doi:10.1023/a:1026404227624 · Cited by 101
Ras - a versatile cellular switch
Rommel, C., & Hafen, E. (1998) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(98)80111-1 · Cited by 101
Verstappen, G., van Grunsven, L. A., Michiels, C., de Putte, T. V., Souopgui, J., Damme, J. V., Bellefroid, E., Vandekerckhove, J. S., & Huylebroeck, D. (2008) · Human Molecular Genetics · doi:10.1093/hmg/ddn007 · Cited by 100
Thomsen, K. G., Lyng, M., Lænkholm, A., Søkilde, R., Nielsen, B. S., Litman, T., & Ditzel, H. J. (2012) · Breast Cancer Research and Treatment · doi:10.1007/s10549-012-1969-9 · Cited by 98
Interaction of embryonic cell surface and cytoskeleton with extracellular matrix
Hay, E. D. (1982) · American Journal of Anatomy · doi:10.1002/aja.1001650102 · Cited by 94
Wienke, D., Davies, G., Johnson, D. A., Sturge, J., Lambros, M. B. K., Savage, K., Elsheikh, S. E., Green, A. R., Ellis, I. O., Robertson, D. M., et al. (2007) · Cancer Research · doi:10.1158/0008-5472.can-06-3496 · Cited by 94
Antiangiogenesis drug promising for metastatic colorectal cancer
McCarthy, M. C. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13603-3 · Cited by 94
Wong, T., Gao, W., & Chan, J. Y. W. (2014) · BioMed Research International · doi:10.1155/2014/921564 · Cited by 94
Quirke, V. M. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00620 · Cited by 92
Rituximab blocks binding of radiolabeled anti-CD20 antibodies (Ab) but not radiolabeled anti-CD45 Ab
Gopal, A. K., Press, O. W., Wilbur, S. M., Maloney, D. G., & Pagel, J. M. (2008) · Blood · doi:10.1182/blood-2008-01-132142 · Cited by 85
Senescence, Wound Healing, and Cancer: the PAI-1 Connection
Kortlever, R. M., & Bernards, R. (2006) · Cell Cycle · doi:10.4161/cc.5.23.3510 · Cited by 84
Sokol, J. P., Neil, J. R., Schiemann, B. J., & Schiemann, W. P. (2005) · Breast Cancer Research · doi:10.1186/bcr1312 · Cited by 83
de Castro, G., Puglisi, F., de Azambuja, E., Saghir, N. S. E., & Awada, A. H. (2006) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2006.02.007 · Cited by 80
Jechlinger, M., Grünert, S., & Beug, H. (2002) · Journal of Mammary Gland Biology and Neoplasia · doi:10.1023/a:1024090116451 · Cited by 79
Role of CK1 in GSK3β-mediated phosphorylation and degradation of Snail
Xu, Y., Lee, S.-H., Kim, H. S., Kim, N. H., Piao, S., Park, S.-H., Jung, Y., Yook, J. I., Park, B.-J., & Ha, N. (2010) · Oncogene · doi:10.1038/onc.2010.77 · Cited by 79
Hyperoxic Treatment Induces Mesenchymal-to-Epithelial Transition in a Rat Adenocarcinoma Model
Moen, I. N., Oyan, A. M., Kalland, K.-H., Tronstad, K. J., Akslen, L. A., Chekenya, M., Sakariassen, P. Ø., Reed, R. K., & Stuhr, L. E. B. (2009) · PLoS ONE · doi:10.1371/journal.pone.0006381 · Cited by 76
Arima, Y., Hayashi, H., Sasaki, M., Hosonaga, M., Goto, T. M., Chiyoda, T., Kuninaka, S., Shibata, T., Ohata, H., Nakagama, H., et al. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.313759 · Cited by 75
Arai, K., Eguchi, T., Rahman, M. M., Sakamoto, R., Masuda, N., Nakatsura, T., Calderwood, S. K., Kozaki, K., & Itoh, M. (2016) · PLoS ONE · doi:10.1371/journal.pone.0162394 · Cited by 75
Epilysin (MMP‐28) – structure, expression and potential functions
Illman, S. A., Lohi, J., & Keski‐Oja, J. (2008) · Experimental Dermatology · doi:10.1111/j.1600-0625.2008.00782.x · Cited by 74
Hamilton, D. H., Litzinger, M. T., Jales, A., Huang, B., Fernando, R. I., Hodge, J. W., Ardiani, A., Apelian, D., Schlom, J., & Palena, C. (2013) · Oncotarget · doi:10.18632/oncotarget.1295 · Cited by 72
Sharkey, R. M., Press, O. W., & Goldenberg, D. M. (2009) · Blood · doi:10.1182/blood-2008-11-188896 · Cited by 69
Sonnenberg, M., van der Kuip, H., Haubeiß, S., Fritz, P., Schroth, W., Friedel, G., Simon, W. E., Mürdter, T. E., & Aulitzky, W. E. (2008) · BMC Cancer · doi:10.1186/1471-2407-8-364 · Cited by 67
Kim, E., Kim, M.-S., & Moon, A. (2004) · Cytokine · doi:10.1016/j.cyto.2004.10.001 · Cited by 65
Zhao, L., Kuppuswamy, M. N., Vijayalingam, S., & Chinnadurai, G. (2009) · BMC Molecular Biology · doi:10.1186/1471-2199-10-89 · Cited by 65
Regulation of Plasminogen Activator Inhibitor-1 Expression by Tumor Suppressor Protein p53
Shetty, S., Shetty, P. K., Idell, S., Velusamy, T., Bhandary, Y. P., & Shetty, R. R. (2008) · Journal of Biological Chemistry · doi:10.1074/jbc.m710268200 · Cited by 62
Wu, Y., Sarkissyan, M., Elshimali, Y., & Vadgama, J. V. (2013) · PLoS ONE · doi:10.1371/journal.pone.0078259 · Cited by 59
Cited by
Unveiling the mechanisms and challenges of cancer drug resistance
Khan, S. U., Fatima, K., Aisha, S., & Malik, F. (2024) · Cell Communication and Signaling · doi:10.1186/s12964-023-01302-1 · Cited by 417
Tumor Necrosis Factor Receptors: Pleiotropic Signaling Complexes and Their Differential Effects
Gough, P., & Myles, I. A. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.585880 · Cited by 268
Breast cancer models: Engineering the tumor microenvironment
Bahcecioglu, G., Basara, G., Ellis, B. W., Ren, X., & Zorlutuna, P. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.02.006 · Cited by 213
Huang, Z., Chu, L., Liang, J., Tan, X., Wang, Y., Wen, J., Chen, J., Wu, Y., Liu, S., Liao, J., et al. (2021) · Hepatology · doi:10.1002/hep.31673 · Cited by 82
Metabolic Rewiring and Redox Alterations in Malignant Pleural Mesothelioma
Urso, L., Cavallari, I., Sharova, E., Ciccarese, F., Pasello, G., & Ciminale, V. (2020) · British Journal of Cancer · doi:10.1038/s41416-019-0661-9 · Cited by 47
Metadata
- Authors
- Das, V., Bhattacharya, S., Chikkaputtaiah, C., Hazra, S., & Pal, M.
- Venue
- Journal of Cellular Physiology
- Publisher
- Wiley
- Published
- 2019-02-05
- Volume
- 234
- Issue
- 9
- Pages
- 14535-14555
- ISSN
- 0021-9541 (ISSN-L)
- 1097-4652
- OpenAlex
- W2911725508
- Cited by
- 263
- References
- 213
- FWCI
- 11.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.